207 related articles for article (PubMed ID: 34628525)
1. The prognostic significance of [
Sachpekidis C; Merz M; Raab MS; Bertsch U; Weru V; Kopp-Schneider A; Jauch A; Goldschmidt H; Dimitrakopoulou-Strauss A
EJNMMI Res; 2021 Oct; 11(1):100. PubMed ID: 34628525
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence-based, volumetric assessment of the bone marrow metabolic activity in [
Sachpekidis C; Enqvist O; Ulén J; Kopp-Schneider A; Pan L; Mai EK; Hajiyianni M; Merz M; Raab MS; Jauch A; Goldschmidt H; Edenbrandt L; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2293-2307. PubMed ID: 38456971
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of visual IMPeTUs criteria and metabolic tumor burden at baseline [
Marchiori S; Cousin F; Papadopoulos I; Bernard C; Thys M; De Prijck B; Pirotte M; Donneau AF; Hustinx R; Caers J; Withofs N
EJNMMI Res; 2024 May; 14(1):51. PubMed ID: 38806885
[TBL] [Abstract][Full Text] [Related]
4. Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).
Nanni C; Zamagni E; Versari A; Chauvie S; Bianchi A; Rensi M; Bellò M; Rambaldi I; Gallamini A; Patriarca F; Gay F; Gamberi B; Cavo M; Fanti S
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):414-21. PubMed ID: 26475305
[TBL] [Abstract][Full Text] [Related]
5. Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).
Nanni C; Versari A; Chauvie S; Bertone E; Bianchi A; Rensi M; Bellò M; Gallamini A; Patriarca F; Gay F; Gamberi B; Ghedini P; Cavo M; Fanti S; Zamagni E
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):712-719. PubMed ID: 29270787
[TBL] [Abstract][Full Text] [Related]
6. Favorable Long-Term Outcomes with Autologous Stem Cell Transplantation for High-Risk Multiple Myeloma Patients with a Positive Result On
Cho HJ; Baek DW; Kim JH; Lee J; Chung YK; Jung SH; Song GY; Ahn SY; Ahn JS; Yang DH; Lee JJ; Kim HJ; Hong CM; Jeong SY; Min JJ; Sohn SK; Moon JH
Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):113-120. PubMed ID: 34598908
[TBL] [Abstract][Full Text] [Related]
7. Treatment response evaluation with
Sachpekidis C; Hillengass J; Goldschmidt H; Wagner B; Haberkorn U; Kopka K; Dimitrakopoulou-Strauss A
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):50-62. PubMed ID: 27573638
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of [
Stolzenburg A; Lückerath K; Samnick S; Speer M; Kneer K; Schmid JS; Grigoleit GU; Hofmann S; Beer AJ; Bunjes D; Knop S; Buck AK; Einsele H; Lapa C
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1694-1704. PubMed ID: 29610955
[TBL] [Abstract][Full Text] [Related]
9. Can
Sachpekidis C; Kopp-Schneider A; Merz M; Jauch A; Raab MS; Goldschmidt H; Dimitrakopoulou-Strauss A
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32456181
[TBL] [Abstract][Full Text] [Related]
10.
Morales-Lozano MI; Rodriguez-Otero P; Sancho L; Nuñez-Cordoba JM; Prieto E; Marcos-Jubilar M; Rosales JJ; Alfonso A; Guillen EF; San-Miguel J; Garcia-Velloso MJ
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077292
[TBL] [Abstract][Full Text] [Related]
11. Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined
Sachpekidis C; Goldschmidt H; Kopka K; Kopp-Schneider A; Dimitrakopoulou-Strauss A
EJNMMI Res; 2018 Apr; 8(1):28. PubMed ID: 29633046
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in the prediction of outcome of patients with multiple myeloma: a comparative study.
Fonti R; Pace L; Cerchione C; Catalano L; Salvatore B; De Luca S; Pane F; Salvatore M; Del Vecchio S
Clin Nucl Med; 2015 Apr; 40(4):303-8. PubMed ID: 25608167
[TBL] [Abstract][Full Text] [Related]
13.
Jung SH; Kwon SY; Min JJ; Bom HS; Ahn SY; Jung SY; Lee SS; Park MR; Yang DH; Ahn JS; Kim HJ; Lee JJ
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):107-115. PubMed ID: 30187105
[TBL] [Abstract][Full Text] [Related]
14. Fluorodeoxyglucose-avid focal lesions and extramedullary disease on 18F-FDG PET/computed tomography predict the outcomes of newly diagnosed symptomatic multiple myeloma patients.
Zhong X; Diao W; Zhao C; Jia Z
Nucl Med Commun; 2020 Sep; 41(9):950-958. PubMed ID: 32796484
[TBL] [Abstract][Full Text] [Related]
15. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Baseline
Moon SH; Choi WH; Yoo IR; Lee SJ; Paeng JC; Jeong SY; Lee SW; Kim K; Choi JY
Korean J Radiol; 2018; 19(3):481-488. PubMed ID: 29713226
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG-PET/CT in relapsed multiple myeloma: Are prognostic thresholds different from first-line therapy?
Zukovs R; Antke C; Mamlins E; Sawicki LM; Mohring A; Lopez Y Niedenhoff D; Boquoi A; Kondakci M; Antoch G; Müller HW; Fenk R; Haas R
BMC Med Imaging; 2022 Apr; 22(1):63. PubMed ID: 35379187
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.
Zamagni E; Patriarca F; Nanni C; Zannetti B; Englaro E; Pezzi A; Tacchetti P; Buttignol S; Perrone G; Brioli A; Pantani L; Terragna C; Carobolante F; Baccarani M; Fanin R; Fanti S; Cavo M
Blood; 2011 Dec; 118(23):5989-95. PubMed ID: 21900189
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of extramedullary disease (EMD) detected on pre-transplant
Yanamandra U; Reddy Gorla AK; Agrawal K; Mittal BR; Prakash G; Khadwal AR; Varma N; Varma S; Malhotra P
Med J Armed Forces India; 2023; 79(6):672-678. PubMed ID: 37981939
[TBL] [Abstract][Full Text] [Related]
20. Multitracer PET/CT with [
Garrastachu Zumarán P; García Megías I; Mangas Losada M; Mendoza Melero A; Villanueva Torres A; Boulvard Chollet X; Romero Robles L; Hernández Pérez PM; Ramírez Lasanta R; Delgado Bolton RC
Diagnostics (Basel); 2023 Apr; 13(9):. PubMed ID: 37174961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
